Who are Nucleusrad's investors?

Nucleusrad's investors include OrbiMed.

How much funding has Nucleusrad raised?

Nucleusrad has disclosed $72.1M raised across 2 rounds.

Where is Nucleusrad headquartered?

Nucleusrad is headquartered in Palo Alto, US.

Nucleusrad

Palo Alto, US · Founded 2022 · 56 employees on LinkedIn · 1 known investors

Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) for targeted radiotherapies and theranostics, providing R&D, GMP manufacturing, and specialized supply-chain logistics from clinical trials through commercial production. It serves radiopharmaceutical companies and operates facilities in Rochester, MN and near Philadelphia, PA.</parameter> <parameter name="hq_city">Rochester

Advanced Manufacturing Biotech Healthtech

Founders & leadership

Tyrell RiversNamed on SEC filing

Mary Kate WoldNamed on SEC filing

Michael RossiNamed on SEC filing

Norman SharplessNamed on SEC filing

Chris McDonaldNamed on SEC filing

Manu NairNamed on SEC filing

Justin ButlerNamed on SEC filing

Charles ConroyNamed on SEC filing

Investors · 1

OrbiMedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$72.1M disclosed across 2 rounds · 2022–2023

▶$66.1MraisedApr 2024 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Tyrell RiversDirector
Mary Kate WoldDirector
Michael RossiDirector
Norman SharplessDirector
Chris McDonaldDirector
Manu NairDirector
Justin ButlerDirector
Charles ConroyExecutive Officer, Director

Offering amount: $66.1M
Amount sold: $66.1M
First sale: Sep 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6MraisedApr 2024 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Charles ConroyExecutive Officer, Director
Justin ButlerDirector
Manu NairDirector
Tyrell RiversDirector
Norman SharplessDirector
Michael RossiDirector
Chris McDonaldDirector
Mary Kate WoldDirector

Offering amount: $6M
Amount sold: $6M
First sale: Oct 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Nucleusrad do?: Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) for targeted radiotherapies and theranostics, providing R&D, GMP manufacturing, and specialized supply-chain logistics from clinical trials through commercial production. It serves radiopharmaceutical companies and operates facilities in Rochester, MN and near Philadelphia, PA.</parameter> <parameter name="hq_city">Rochester
Who are Nucleusrad's investors?: Nucleusrad's investors include OrbiMed.
How much funding has Nucleusrad raised?: Nucleusrad has disclosed $72.1M raised across 2 rounds.
Where is Nucleusrad headquartered?: Nucleusrad is headquartered in Palo Alto, US.